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Abstract
Background: In the bovine species milk production is well known to correlate with mammary tissue mass. However, most
advances in optimizing milk production relied on improvements of breeding and husbandry practices. A better
understanding of the cells that generate bovine mammary tissue could facilitate important advances in milk production and
have global economic impact. With this possibility in mind, we show that a mammary stem cell population can be
functionally identified and isolated from the bovine mammary gland. We also demonstrate that this stem cell population
may be a promising target for manipulating the composition of cow’s milk using gene transfer.
Methods and Findings: We show that the in vitro colony-forming cell assay for detecting normal primitive bipotent and
lineage-restricted human mammary clonogenic progenitors are applicable to bovine mammary cells. Similarly, the ability of
normal human mammary stem cells to regenerate functional bilayered structures in collagen gels placed under the kidney
capsule of immunodeficient mice is shared by a subset of bovine mammary cells that lack aldehyde dehydrogenase activity.
We also find that this activity is a distinguishing feature of luminal-restricted bovine progenitors. The regenerated structures
recapitulate the organization of bovine mammary tissue, and milk could be readily detected in these structures when they
were assessed by immunohistochemical analysis. Transplantation of the bovine cells transduced with a lentivirus encoding
human b-CASEIN led to expression of the transgene and secretion of the product by their progeny regenerated in vivo.
Conclusions: These findings point to a common developmental hierarchy shared by human and bovine mammary glands,
providing strong evidence of common mechanisms regulating the maintenance and differentiation of mammary stem cells
from both species. These results highlight the potential of novel engineering and transplant strategies for a variety of
commercial applications including the production of modified milk components for human consumption.
Citation: Martignani E, Eirew P, Accornero P, Eaves CJ, Baratta M (2010) Human Milk Protein Production in Xenografts of Genetically Engineered Bovine Mammary
Epithelial Stem Cells. PLoS ONE 5(10): e13372. doi:10.1371/journal.pone.0013372
Editor: Joseph Najbauer, City of Hope National Medical Center, United States of America
Received May 14, 2010; Accepted September 20, 2010; Published October 19, 2010
Copyright:  2010 Martignani et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Canadian Cancer Society, the Canadian Bank of Commerce, Regione Piemonte, and the CRC Foundation
with core support provided by the British Columbia Cancer Foundation and the University of Turin. Peter Eirew held a United States Department of Defense Breast
Cancer Research Program Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mario.baratta@unito.it
. These authors contributed equally to this work.
Introduction
Normal mammalian mammary tissue is a bilayered system
organized into alveolar structures connected by a common ductal
system. The two cell layers are separate but contiguous throughout
and consist of an inner layer of cytokeratin(CK)18+ luminal cells and
an outer layer of CK14+myoepithelial cells. The luminal cells in the
alveoli can produce milk, while the contractile myoepithelial cells
are responsible for forcing the secreted milk to the teat cistern [1].
Studies of mammary cells from both mice and humans suggest that
the luminal and myoepithelial cells are separately derived from
phenotypically distinct lineage-restricted progenitors that, in turn,
arise ultimately from a population of bipotent mammary cells with
extensive self-renewal capacity [2–6]. The mammalian mammary
gland is thus believed to represent a typical hierarchically organized
epithelial tissue originating from a stem cell population that is
maintained throughout adult life [7,8]. Current methods for
detecting human and mouse mammary progenitors require the
preparation of viable single-cell suspensions and their assessment in
suitable in vitro or in vivo assays to detect the growth and
differentiation properties of the input cells at a clonal level. Because
of the genetic homogeneity of inbred mouse strains, transplantation
of cells from one mouse to another of the same strain is feasible. In
addition, the use of the cleared mammary fat pad of weanling
female recipient mice as an in vivo ‘‘niche’’ has proven to be an ideal
system to reveal the ability of single murine mammary stem cells to
regenerate a complete lactating mammary structure within 6 weeks
[2,3]. Detection of humanmammary stem cells has taken advantage
of the creation of genetically immunodeficient strains of mice that
lack a normal complement of natural killer cells as well as B and T
cells [9] to enable in vivo transplant assay strategy to be developed.
These make use of a fibroblast-enhanced mammary fat pad or gel
implants containing fibroblasts as well as the test cells to create a
suitable growth-promoting environment [4,10,11].
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To date very little information about the origin and regulation
of bovine mammary cells has been generated. Ellis and Capuco
[12] used a histological and morphological approach to show the
existence of a small population of light staining mammary
epithelial cells that constitutes approximately 50% of the
proliferating mammary population. More recently Capuco [13]
investigated the distribution of label-retaining epithelial cells
(LREC) in pre-pubertal cows based on previous, albeit now
contested [14,15], reports that adult epithelial stem cells have this
property [16,17]. We now report the first description of bovine
mammary progenitors and stem cells defined by functional growth
endpoints using the same in vitro and in vivo xenotransplant systems
previously developed for their human counterparts. In addition,
we demonstrate the efficient transduction of these cells with a
human b-CASEIN cDNA-encoding lentiviral vector which results
in readily detectable protein production in the bovine mammary
tissue subsequently regenerated in mice transplanted with
transduced cells.
Results
Identification of bovine mammary progenitor cells
We first sought to determine whether the methods developed for
quantifying human mammary cells with in vitro clonogenic
potential would enable the detection of analogous populations in
bovine mammary tissue. Single cell suspensions were prepared
from a total of eight samples of mammary tissue from cows
ranging in age from 7 months to 14 years and representing
different stages of mammary development (prepubertal, virgin
adult and late lactation). Colony-Forming Cell (CFC) assays were
then performed with these cells. In every experiment distinct large
colonies were generated within 6–9 days. Colony frequencies
ranged in different samples from 1 colony per 3 to 2000 cells
plated. The colonies contained cells that expressed CK typical of
differentiated luminal (CK18) or myoepithelial cells (CK14)
(Figure 1a). Colonies containing mostly cells expressing CK14
but not CK18 were comprised of tightly packed small polygonal
cells with a reduced cytoplasm. Many of these ‘‘myoepithelial’’
colonies contained larger cells in the center of the colony
surrounded by smaller cells. Colonies containing CK18+ cells
(‘‘luminal’’ colonies) were composed of spindle-shaped cells with
well defined nuclei and an extended cytoplasm. Some of these
colonies contained very few cells with a very extended cytoplasm
and an irregular shape. These findings are consistent with the
presence in bovine mammary tissue of both luminal and
myoepithelial-restricted progenitor cells each of which can
proliferate in vitro in response to stimulation by epidermal growth
factor (EGF), insulin and unknown factors produced by mouse
fibroblasts.
Bovine mammary cells regenerate mammary tissue in an
in vivo xenograft assay
We next asked whether dissociated bovine mammary tissue also
contained cells with in vivo mammary tissue regenerative activity -
similar to that exhibited by mouse or human mammary stem cells.
Accordingly, we transplanted additional aliquots of dissociated
bovine mammary cells into cleared mammary fat pads of 3-week-
old immunodeficient female NOD/SCID or NOD/SCID-IL-2
receptor gamma chain-null (NSG) mice (as per the assay for mouse
mammary stem cells). Other aliquots were suspended together
with mouse 10T1/2 fibroblasts in collagen gels which we then
transplanted under the kidney capsule of young adult female
NOD/SCID or NSG mice. Very poor growth of any mammary
tissue was obtained in the cleared fat pad assay (evaluated 6 weeks
later, data not shown) as previously reported for human mammary
cells transplanted into this environment. In contrast, all 5 samples
transplanted in the fibroblast-supplemented gels placed under the
kidney capsule gave rise to histologically recognizeable mammary
structures within 4 weeks (Figure 1b, iv–vi). From estimates of the
number of structures seen in at least 3 groups of consecutively
sectioned gels, we estimate that, on average, 1 structure was
produced per 1,500 to 15,000 cells originally suspended in the gel.
Most of the outgrowths appeared to be spherical in shape with a
well defined lumen surrounded by 2 layers of cells. However,
occasionally more complex bilayered structures with duct-like
branching projections were also noted. The inner cell layer of
these structures was composed of cuboidal cells that were weakly
CK18+, consistent with a luminal phenotype. The outer layer
consisted of more elongated cells with flattened nuclei and these
cells were strongly positive for CK14, a-SMA and p63, consistent
with a basal-myoepithelial phenotype. The regenerated structures
were surrounded by laminin-1, a key component of the basement
membrane that normally circumscribes the mammary gland in
vivo. In addition, we found that the nucleus of a small number of
cells within each structure stained strongly with antibodies to the
progesterone receptor. Immunohistochemical evidence of milk
proteins in the lumen of the pseudo-alveoli regenerated in hosts
that had become pregnant was also obtained (Figure 1b, viii–ix).
To determine whether the structures produced in the gels
contained detectable clonogenic progenitors, we dissociated some
of the gels in collagenase to obtain single cell suspensions and then
plated these in vitro. These experiments showed the formation of
the same two types of colonies as seen in assays of freshly isolated
bovine mammary cells. However, as illustrated in Figure 1c, in the
assays of the dissociated regenerated structures, we also noted the
presence of many ‘‘mixed’’ colonies (containing both CK14+ and
CK18+ cells within the same colony).
ALDH1+ bovine mammary cells are selectively enriched
in luminal progenitors
We next sought to determine whether bovine cells with in vitro
clonogenic or in vivo regenerative activity could be prospectively
enriched within distinct subsets of cells. Unfortunately, an
evaluation of antibodies against antigens expressed on primitive
human and mouse mammary cells (CD24, CD29, CD49f,
EpCAM and MUC1) failed to detect any that showed cross-
reactivity with bovine cells (data not shown). These findings
precluded the adoption of most cell separation strategies previously
used to discriminate subsets of primitive mouse and human
mammary cells. We therefore turned to an alternative approach
that allows cells to be separated based on their aldehyde
dehydrogenase (ALDH) activity using a reagent that is not
species-restricted. Figure 2a–b shows a representative distribution
of viable cells obtained from bovine mammary tissue, in this case
from a pubertal virgin cow after staining and FACS analysis of the
cells according to their ALDH activity (31% ALDHhigh and 67%
ALDH1low). As shown in Figure 2c, assessment of the distribution
of clonogenic cells in the sorted ALDHhigh and ALDHlow fractions
isolated from 3 different animals showed that almost all of the
colonies produced by the ALDHhigh cells had luminal features.
Conversely, most of the colonies produced by the ALDHlow
fraction had myoepithelial features (progenitor frequencies are
shown in Table 1).
When we then assayed proportional aliquots of the same 2
fractions in the kidney capsule assay, we found that very few
outgrowths were produced in the gels initially seeded with the
ALDHhigh cells (0–2 structures per gel, n = 4). In marked contrast,
many extended and confluent structures were seen in the gels that
Mammary SCs Secrete Transgene
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Figure 1. Differentiation markers expression analysis in bovine mammary colonies and xenografts. Representative pictures of a
luminal-like colony (panel A, i–iii) and a myoepithelial-like colony (panel A, iv–vi) showing the differential expression of mammary lineage-restricted
cytokeratins (CK). Panel B, i–iii shows the expression and spatial localization of immunofluorescently detected mammary epithelial cell markers in
bovine mammary tissue. Panel B, iv–vi shows the expression and spatial localization of the same immunofluorescently detected markers in
regenerated structures. The expression of milk proteins (B, vii) were detected with an Alexa-488 labelled secondary antibody, while laminin-1 (B, viii)
and a-smooth muscle actin (SMA) (B, ix) were detected using DAB substrate and Fast-Red, respectively. Panel c shows representative ‘‘mixed’’
colonies generated in colony forming assays performed on cells from 4 weeks xenografts. Panel C, i–iii shows part of a single large colony containing
CK14+CK182 cells (arrow), CK142CK18+ cells (dashed arrow) and CK14+CK18+ cells (arrow tip). Panel C, iv–vi shows part of another large colony where
most of the cells are CK14+CK18+. Scale bars in panel A and C is 250 mm, in panel B is 25 mm.
doi:10.1371/journal.pone.0013372.g001
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had been seeded with the ALDHlow bovine cells (more than 15
structures per gel, n = 4). Importantly the structures obtained from
the purified cells were indistinguishable histologically or by
immunocytochemistry from those generated from unseparated
cells.
Expression of a human gene in bovine mammary tissues
regenerated in mice from transplanted bovine mammary
cells genetically engineered in vitro
We created a lentiviral GFP vector encoding a human b-
CASEIN cDNA and then used it to transduce sorted ALDH1low
mammary epithelial cells as described in the Experimental
Procedures. The transduced cells were then immediately embed-
ded in collagen gels and the gels inserted under the kidney capsule
of female NOD/SCID mice which were made pregnant 1 week
later. After another 3 weeks we removed the gels and subjected
them to various immunohistochemical analyses. The results
showed that the engineered ALDHlow cells had regenerated the
same bilayered mammary structures as seen previously and that
immunoreactive human b-CASEIN was clearly evident in the
lumen of some of the regenerated structures (1 to 3 per xenograft)
(Figure 3c).
Discussion
Our findings indicate that the bovine mammary gland, like that
of mice and humans, is organized as a developmental hierarchy
originating in a population of phenotypically distinct mammary
stem cells, each of which is endowed with the ability to regenerate
and maintain a complete mammary gland structure [18]. This
process appears to involve the commitment of the mammary stem
Figure 2. FACS profiles of bovine mammary cells stained for ALDH activity. Cells were stained with ALDEFLUOR with (a) or without (b)
diethylamino-benzaldehyde (DEAB), an ALDH inhibitor. Panel c shows the proportional distribution of total clonogenic luminal and myoepithelial
progenitors between the Aldehyde Dehydrogenase (ALDH)high and ALDHlow fractions (% of all progenitors of a given type in the fraction shown 6
SEM, n = 3).
doi:10.1371/journal.pone.0013372.g002
Table 1. Comparison of the frequency of clonogenic
progenitors in the isolated Aldehyde Dehydrogenase
(ALDH)high and ALDHlow fractions of bovine mammary cells
(n = 3).
Sample Colony frequency ALDHhigh (%) ALDHlow (%)
1 CK14+ colonies 0.13 24.00
CK18+ colonies 6.38 1.63
2 CK14+ colonies 0.01 0.1
CK18+ colonies 2.51 0.05
3 CK14+ colonies 0.01 0.06
CK18+ colonies 0.21 0.02
Samples are: 1. 11 months old Piedmontese; 2. 7 months old Red Angus; 3. 12
months old Black Angus.
doi:10.1371/journal.pone.0013372.t001
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cells to either a luminal (CK18+) or a myoepithelial (CK14+)
differentiation pathway through a series of coordinated events that
precede the ultimate loss of an ability to proliferate further. Thus
under in vitro conditions permissive for the differentiation of both
mammary cell lineages, uni-lineage colonies (containing either
CK18+ or CK14+ cells but not both) may be inferred to be
derived from progenitors already committed to either the luminal
or myoepithelial lineages, and mixed colonies (containing both) are
inferred to be derived from a more primitive uncommitted
(bipotent) progenitor class. The fact that the progenitors of luminal
and myoepithelial colonies can be prospectively isolated based on
their ALDH activity provided strong support for this interpreta-
tion. Unexpectedly, we found that the bovine colonies containing
mostly CK14+ cells were composed of tightly packed cells and in
those containing mostly CK18+ cells the cells showed a looser
organization. Although these morphologies are the reverse of what
has been seen in similar assays of mouse and human mammary
cells [5,6,19], the findings for bovine mammary colonies were
consistent for all samples tested. Notably, the structures regener-
ated in vivo showed the same expression of markers observed in
primary bovine mammary tissue with polygonal CK18+ cells lining
the lumen surrounded by CK14+ cells. Given the plasticity of
morphology of primary epithelial cells that can be encountered
when these are cultured at low density in 2D systems, we felt more
confidence in relying on CK expression to infer lineage
assignments for the in vitro generated cells. However, this does
highlight the need for caution when interpreting data from in vitro
assays.
The observed prevalence of mixed colonies in assays of cells
isolated from regenerated structures is similar to what we have
seen in similar assays of human cells and likely reflects the early
regenerative phase of the structures from which they were
obtained. In addition, the niche requirements of these primitive
bovine mammary stem cells appear to more closely resemble
those of their human rather than their murine counterparts since
they regenerated structures in the kidney capsule assay but not
when injected directly into cleared mouse mammary fat pads
[4,10,11].
ALDH expression has been associated with normal hematopoi-
etic cell populations that possess a high stem/progenitor content
and has also been reported to be a poor prognostic marker in
several types of cancer, including breast cancer [20–24].
It is important to note that high ALDH activity distinguished
luminal progenitors from both myoepithelial clonogenic progen-
itors and bovine mammary stem cells with in vivo regenerative
activity. This adds to an extensive literature documenting a shared
basal phenotype of human and murine mammary stem cells and
myoepithelial progenitors and a luminal phenotype of luminal-
restricted progenitors [8,25–29]. This differential expression of
ALDH activity allowed us to obtain an enrichment in the stem cell
content of the initial suspension by selective removal of the luminal
progenitors (ALDHhigh cells). Although these ALDH results differ
from those published by Ginestier C. et al [23] those authors used a
different in vivo assay system and correlated their findings with cells
that initiated mammosphere formation in vitro. Moreover, we have
found that the distribution of ALDH activity amongst different
types of primitive normal human mammary cells parallels that
shown here for bovine mammary cells when the same types of
functional assay procedures are applied (P. Eirew and C. Eaves,
unpublished data).
Of particular significance in the context of this report is our
demonstration of an ability of the regenerated bovine mammary
structures to secrete milk proteins. The ability to introduce
transgenes into ruminant mammary stem cells to produce proteins
of interest, including those normally present in human milk, is an
important discovery. This finding could have many applications in
biotechnology considering the high milk output that can be
obtained from breeds like the Holstein-Frisian and the ease of
protein recovery from secreted milk. Because of the length and
complexity of current procedures for obtaining transgenic cows,
such a transgenic strategy in combination with the type of
transplant-based approach shown here to be feasible could have
significant commercial potential.
Materials and Methods
Mice
Female NOD/SCID mice were bred and housed at the animal
facility of the Faculty of Veterinary Medicine of the University of
Turin according to the procedures and guidelines approved by
the Italian Ministry of Health. Female NOD/SCID-interleukin-2
receptor-cc-null (NSG) mice were bred and housed at the animal
facility of the British Columbia Cancer Research Centre accord-
ing to procedures approved by the University of British Columbia
Animal Care Committee. Animal work described in this study
has been reviewed and approved by the Italian Ministry of
Health and the University of British Columbia Animal Care
Committee, study number A06-1520. Both strains were used at 5
to 10 weeks of age as equivalent recipients for the transplants
described.
Figure 3. Human b-CASEIN expression in regenerated bovine alveoli. Representative photomicrographs showing in bovine lactating
mammary tissue the presence of milk proteins in the lumen of an alveolus (a) and the absence of crossreactivity of the antibody used to detect
human b-CASEIN (b). In (c) the expression and localization in the lumen of recombinant human b-CASEIN is evident in outgrowths formed by cells
transduced with the human b-cas-pWPI lentiviral vector. Scale bar is 25 mm.
doi:10.1371/journal.pone.0013372.g003
Mammary SCs Secrete Transgene
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Bovine mammary tissue
Whole udders were collected from cows of different breeds
(dairy and beef) and age (7 months to 14 years) at local abattoirs 30
minutes to 3 hours after slaughter. Sample collection was
performed with the authorization and under the supervision of
representatives of the Veterinary Services of the Italian National
Health Service branch of the Ministry of Health. A piece of tissue
was dissected out of the area surrounding the teats and then
minced with scalpels. Approximately 10–15 grams of tissue were
transferred to a 125 ml baffled Erlenmeyer flask containing 20 ml
of a 1:1 v/v mixture of Dulbecco’s Modified Eagle Medium/
Nutrient Mixture F12 Ham (DMEM/F12) supplemented with 2%
w/v bovine serum albumin (BSA, Fraction V), 300 U/ml
collagenase, 100 U/ml hyaluronidase, 100 U/ml penicillin,
100 mg/ml streptomycin (all from STEMCELL Technologies,
Vancouver, BC, Canada). The tissue was then placed in a shaking
incubator at 37uC for 18–20 hours. A fraction enriched in
epithelial cell aggregates (organoids) was next obtained by
centrifugation of the dissociated tissue at 80 g for 30 seconds
and then washed in fresh DMEM/F12 medium at least 3 times.
The organoids were then frozen in 6% dimethyl sulfoxide
(DMSO, Fluka, Milan, Italy) containing medium and stored at
280uC until further processed. To prepare single cell suspensions,
organoids were thawed and incubated with a 0.5 mg/ml trypsin
solution supplemented with 0.2 mg/ml EDTA followed by
vigorous pipetting for 4 minutes and subsequent washing in
Hank’s balanced salt solution (HBSS, STEMCELL Technologies)
supplemented with 2% FBS. Cells were then treated with 5 mg/
ml dispase and 100 mg/ml DNAseI (STEMCELL Technologies)
and passed through a 40 mm cell strainer (BD Biosciences, San
Jose, CA, USA) to remove remaining cell aggregates.
Colony-Forming Cell (CFC) assay
60 mm tissue culture dishes were coated with collagen by
incubation for 1 hour at 37uC with a solution of rat tail type 1
collagen (80 ml of rat tail type I collagen @ 3.66 mg/ml, BD
Bioscience diluted in 50 ml of a 2% acetic acid solution
(STEMCELL Technologies). Bovine mammary cells were then
added together with 26105 NIH 3T3 mouse fibroblasts previously
either irradiated with 50 Gy 250 KvP X-rays or treated with
10 mg/ml mitomycin C (Sigma-Aldrich, Milan, Italy) for 2 hours
in human EpiCult B medium supplemented with 5% FBS,
1026 M hydrocortisone (Sigma-Aldrich), 100 U/ml penicillin and
100 mg/ml streptomycin. The assay dishes were then incubated at
37uC with 5% CO2 for 24 hours at the end of which the medium
was exchanged for fresh medium of the same composition but
without FBS. Cells were incubated for another 6–9 days and then
the cultures were fixed with acetone/methanol (1:1 v/v, Fluka)
and either stained with Wright’s Giemsa (Sigma-Aldrich) or with a
crystal violet solution (50 mg crystal violet in a 20% methanol
solution, Sigma-Aldrich). Fixed colonies were immunostained (as
described below) with antibodies to human CK14 (1:500 dilution,
polyclonal AF-64, Covance, Princeton, NJ, USA), CK18 (1:200
dilution, clone KS-B17.2, Sigma-Aldrich) and a-smooth muscle
actin (a-SMA, 1:100 dilution, clone 1A4, Sigma-Aldrich), after
validation that all of these cross-reacted with bovine antigens.
Colonies containing more than 50 cells (after 7 days of culture) or
than 100 cells (after 10 days of culture) were then counted and
progenitor frequencies expressed as the total number of colonies
obtained per 100 cells seeded.
Xenotransplants
Concentrated rat tail collagen was prepared as previously
described [30]. A ready to use collagen solution was made by
mixing 88% concentrated collagen, 10% 106 DMEM and 2%
10 M NaOH to neutralize the pH and kept on ice. Collagen gels
were prepared as previously described [4]. Each gel contained
1.66105 10T1/2 fibroblasts previously irradiated with 15 Gy 250
KvP X-rays or treated with 2 mg/ml mitomycin C and 2.56104–
7.56104 bovine primary mammary cells. The gels were kept on ice
until surgically implanted.
Anesthetized mice were shaved in the posterior dorsal area and
cleaned with 70% ethanol. At first a 2 cm anterior-to-posterior cut
was made through the skin along a median line followed by a
smaller incision of approximately 4–5 mm in the abdominal wall
directly above the kidney position. The kidney was then gently
pushed out through the cut, the kidney capsule was lifted and a
short incision of 2–3 mm was made in it. The collagen gels were
then pushed under the capsule using fire polished glass pipette tips.
The abdominal wall was then sutured and the procedure was
repeated on the contra-lateral kidney. In some experiments a slow-
release pellet containing 2 mg b-estradiol (Sigma-Aldrich) and
4 mg progesterone (Sigma-Aldrich) in silicone (MED-4011, NuSil
Technology, Carpinteria, CA, USA) was placed subcutaneously
before finally suturing together the skin of the mouse. In other
experiments the mice were mated 1 or 3 weeks after the surgery.
Cell separation
Bovine mammary cells to be stained with labeled antibodies
were first incubated in HBSS supplemented with 2% FBS.
Antibodies evaluated were fluorescein isothiocyanate (FITC)-
conjugated mouse antibody to human EpCAM (clone VU1-D9,
STEMCELL Technologies), allophycocyanin (APC)-conjugated
rat antibody to human CD49f (clone GOH3, R&D systems,
Minneapolis, MN, USA), phycoerythrin(PE)-conjugated rat anti-
body to mouse CD24 (clone M1/69, BD Biosciences Pharmin-
gen,San Diego, CA, USA), APC-Cy7-conjugated mouse antibody
to human CD29 (clone TS2/19, Biolegend, San Diego, CA,
USA), unconjugated mouse antibody against human MUC1
(clone 214D4, STEMCELL Technologies) and unconjugated
mouse antibody against human CD24 (clone 8.B.76, Abcam,
Cambridge, MA, USA). When unconjugated purified antibodies
were used, incubation with the primary antibodies was followed by
labeling with a PE-conjugated goat antibody against mouse IgG
(Jackson ImmunoResearch, West Grove, PA, USA). Cells were
subsequently analyzed with a FACSCalibur (Becton Dickinson,
San Jose, CA, USA).
Bovine mammary cells with ALDH activity (ALDHhigh cells)
were detected after staining using the ALDEFLUOR Assay Kit
(STEMCELL Technologies) according to the supplier’s instruc-
tions and a 1 mg/ml propidium iodide (PI, Sigma-Aldrich) solution
to discriminate live cells. ALDHhigh and ALDHlow cells were
isolated using a FACSVantage SE (Beckton Dickinson).
Immunostaining
Four to 7 mm sections were dewaxed and processed either for
immunohistochemistry or immunofluorescence. Briefly, after
dewaxing, sections were placed in Tris-HCl buffered saline
supplemented with Tween-20 (TBS-Tween, 0.1 M Tris HCl,
0.14 M NaCl, 0.05% Tween-20, pH 7.6, all reagents from Sigma-
Aldrich) for 10 minutes, then incubated at room temperature for
1 hour in TBS-Tween supplemented with 10% goat serum
(Sigma-Aldrich) and then for 1 hour at room temperature with
one or two primary antibodies as required. Sections were then
washed 3 times with TBS-Tween, secondary antibodies applied,
and sections incubated for another hour. Where alkaline
phosphatase (AP) conjugated polymer (Envision kit, DAKO,
Glostrup, Denmark) or horseradish peroxidase (HRP)-conjugated
Mammary SCs Secrete Transgene
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secondary antibody (Discovery Universal Secondary Antibody kit,
Ventana, Tucson, AZ, USA) was to be used, sections were treated
with a suitable substrate (BCIPH/NBT from Sigma or Fast-Red
from Thermo Scientific for AP, 3,39-diaminobenzidine, DAB,
from Ventana for HRP). Sections were then counterstained with
either Meyer’s hematoxylin (Bio-Optica, Milan, Italy) or 49,6-
diamidino-2-phenylindole (DAPI, Sigma-Aldrich) and then
mounted. To stain colonies grown in tissue culture treated dishes,
cells were fixed with methanol/acetone (1:1 v/v) for 30 seconds to
1 minute, blocked with TBS-Tween supplemented with 10% goat
serum and then stained as described above.
Primary antibodies used were antibodies to human CK14,
CK18, a-SMA, p63 (1:200 dilution, clone 4A4, Thermo Fisher
Scientific, Fremont, CA, USA), Laminin-1 (1:50 dilution,
polyclonal, Sigma-Aldrich), progesterone receptor (PR, 1:70
dilution, clone hPRa 2, Thermo Fisher Scientific), milk proteins
(1:500 dilution, polyclonal Nordic Immunology, Tilburg, Nether-
lands), and b-casein (1:70 dilution, clone F14.20, Harlan
Laboratories, Madison, WI, USA). Secondary antibodies used
were AlexaFluorH 488-labelled goat anti-rabbit IgG and Alexa-
FluorH 594-labelled goat anti-mouse IgG (both from Invitrogen,
Carlsbad, CA, USA).
Negatively stained controls were performed for each antigen by
replacing the primary antibody with a suitable isotype (normal
mouse IgG or normal rabbit IgG from Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA) at the same concentration.
Generation of a human b-casein lentiviral vector
The NIH Mammalian Gene Collection was searched for
a full human b-CASEIN cDNA clone (Acc. No. BC096197). A
pCR-BluntII-TOPO vector containing the full cDNA (IR-
AMp995F082Q) was provided by ImaGenes (Berlin, Germany).
The b-CASEIN open reading frame was cut from the backbone
using EcoRI (Fermentas, St. Leon-Rot, Germany) digestion and
ends blunted by incubation with T4 polymerase (Roche Applied
Science, Monza, Italy). The fragment was then purified and
cloned into the PmeI site of the pWPI plasmid (Addgene,
Cambridge, MA, USA) to generate pWPI-b-cas. The insert
orientation was tested by size analysis of KpnI/NdeI double
digestion fragments. A VSVG enveloped pWPI-b-cas lentiviral
vector (Lenti-b-cas-GFP) preparation was produced by transfect-
ing plasmids from a 3rd generation system (pMDLg/pRRE,
pRSV-Rev, pMD2.G, Addgene) into 293 T cells and the
preparation was then concentrated by ultracentrifugation
(25,000 rpm for 90 minutes at 4uC), aliquoted, titrated and frozen
in liquid nitrogen. HeLa cells were incubated with the Lenti-b-cas-
GFP vector, infection confirmed by detection of GFP and human
b-CASEIN transgene expression measured in extracted RNA by
Real Time (RT)-PCR. For this RNA was extracted using the
RNeasy Mini Kit (QIAGEN, Mississauga, ON, Canada), reverse-
transcribed with SuperScript II Reverse Transcriptase (Invitrogen)
following the manufacturer’s protocols and then RT-PCR
performed.
Infection of bovine primary mammary cells
56105–16106 isolated bovine mammary cells were resuspended
in 120 ml HBSS supplemented with 2% FBS and Lenti-b-cas-GFP
added at a multiplicity of infection (m.o.i.) of 20. The volume was
then adjusted to 200 ml with HBSS and the cells incubated for
4 hours on ice. After washing the cells, half of them were seeded
into a tissue culture dish to evaluate the infection efficiency (%
GFP+ cells after 24–48 hours in vitro) and the remaining cells
were used immediately for kidney xenografts.
Real Time RT-PCR
The quantity of human b-CASEIN transcript expression was
measured relative to the amount of bovine Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) that was used as housekeeping gene to
correct for RNA concentration and reverse transcription efficien-
cy. PCR amplification was carried out using iQ SYBR Green
Supermix (Bio-Rad, Segrate, Italy) in a MJ Mini Cycler equipped
with a MJ Mini-Opticon Real Time PCR detector. Primers for
human b-CASEIN were: forward 59-GCA GCA AGG AGA GGA
TGA-39; reverse 59-GGT ATC GTT GGA GAT TTA AG-39.
Primers for GAPDH were: forward 59-TGCACCACCAACT-
GCTTAGC-39; reverse 59-GGCATGGACTGTGGTCATGAG-
39. 45 PCR cycles were set as following: cycle 1, 94uC for 29; cycle
2, 94uC for 450, 45 cycles at 55uC for 300. Quantification was
done using the D (DCt) method as described by Livak and
Schmittgen[31].
Acknowledgments
The authors are grateful to Glen Edin, Margaret Hale, Darcy Wilkinson
and Cristina Cecere for technical assistance. The authors would like to
thank Prof. Gaetano Donofrio for helpful discussions.
Author Contributions
Conceived and designed the experiments: CJE mb. Performed the
experiments: EM PA. Analyzed the data: mb. Contributed reagents/
materials/analysis tools: PE. Wrote the paper: EM.
References
1. Capuco AV, Ellis S, Wood DL, Akers RM, Garrett W (2002) Postnatal
mammary ductal growth: three-dimensional imaging of cell proliferation, effects
of estrogen treatment, and expression of steroid receptors in prepubertal calves.
Tissue Cell 34: 143–154.
2. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, et al. (2006) Purification
and unique properties of mammary epithelial stem cells. Nature 439: 993–997.
3. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, et al. (2006)
Generation of a functional mammary gland from a single stem cell. Nature 439:
84–88.
4. Eirew P, Stingl J, Raouf A, Turashvili G, Aparicio S, et al. (2008) A method for
quantifying normal human mammary epithelial stem cells with in vivo
regenerative ability. Nat Med 14: 1384–1389.
5. Stingl J, Raouf A, Emerman JT, Eaves CJ (2005) Epithelial progenitors in
the normal human mammary gland. J Mammary Gland Biol Neoplasia 10:
49–59.
6. Raouf A, Zhao Y, To K, Stingl J, Delaney A, et al. (2008) Transcriptome
analysis of the normal human mammary cell commitment and differentiation
process. Cell Stem Cell 3: 109–118.
7. Smith GH, Medina D (1988) A morphologically distinct candidate for an
epithelial stem cell in mouse mammary gland. J Cell Sci 90(Pt 1): 173–183.
8. Kordon EC, Smith GH (1998) An entire functional mammary gland may
comprise the progeny from a single cell. Development 125: 1921–1930.
9. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, et al. (1995)
Multiple defects in innate and adaptive immunologic function in NOD/LtSz-
scid mice. J Immunol 154: 180–191.
10. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, et al. (2004)
Reconstruction of functionally normal and malignant human breast tissues in
mice. Proc Natl Acad Sci U S A 101: 4966–4971.
11. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, et al. (2009) Aberrant luminal
progenitors as the candidate target population for basal tumor development in
BRCA1 mutation carriers. Nat Med 15: 907–913.
12. Ellis S, Capuco AV (2002) Cell proliferation in bovine mammary epithelium:
identification of the primary proliferative cell population. Tissue Cell 34:
155–163.
13. Capuco AV (2007) Identification of putative bovine mammary epithelial stem
cells by their retention of labeled DNA strands. Exp Biol Med (Maywood) 232:
1381–1390.
14. Kiel MJ, He S, Ashkenazi R, Gentry SN, Teta M, et al. (2007) Haematopoietic
stem cells do not asymmetrically segregate chromosomes or retain BrdU. Nature
449: 238–242.
Mammary SCs Secrete Transgene
PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13372
15. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, et al. (2007)
Identification of stem cells in small intestine and colon by marker gene Lgr5.
Nature 449: 1003–1007.
16. Shinin V, Gayraud-Morel B, Gomes D, Tajbakhsh S (2006) Asymmetric division
and cosegregation of template DNA strands in adult muscle satellite cells. Nat
Cell Biol 8: 677–687.
17. Smith GH (2005) Label-retaining epithelial cells in mouse mammary gland
divide asymmetrically and retain their template DNA strands. Development 132:
681–687.
18. Stingl J, Raouf A, Eirew P, Eaves CJ (2006) Deciphering the mammary epithelial
cell hierarchy. Cell Cycle 5: 1519–1522.
19. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, et al.
(2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and
luminal-cell differentiation. Nat Cell Biol 9: 201–209.
20. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, et al. (2009) Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic stem cells
(SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69:
3382–3389.
21. Burger PE, Gupta R, Xiong X, Ontiveros CS, Salm SN, et al. (2009) High
aldehyde dehydrogenase activity: a novel functional marker of murine prostate
stem/progenitor cells. Stem Cells 27: 2220–2228.
22. Jean E, Laoudj-Chenivesse D, Notarnicola C, Rouger K, Serratrice N, et al.
(2009) Aldehyde dehydrogenase activity promotes survival of human muscle
precursor cells. J Cell Mol Med [EPub Ahead of Print].
23. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a
predictor of poor clinical outcome. Cell Stem Cell 1: 555–567.
24. Storms RW, Green PD, Safford KM, Niedzwiecki D, Cogle CR, et al. (2005)
Distinct hematopoietic progenitor compartments are delineated by the
expression of aldehyde dehydrogenase and CD34. Blood 106: 95–102.
25. Stingl J (2009) Detection and analysis of mammary gland stem cells. J Pathol
217: 229–241.
26. Badders NM, Goel S, Clark RJ, Klos KS, Kim S, et al. (2009) The Wnt receptor,
Lrp5, is expressed by mouse mammary stem cells and is required to maintain the
basal lineage. PLoS One 4: e6594.
27. Hanker L, Karn T, Ruckhaeberle E, Gaetje R, Solbach C, et al. (2010) Clinical
relevance of the putative stem cell marker p63 in breast cancer. Breast Cancer
Res Treat 122: 765–775.
28. Tiede BJ, Owens LA, Li F, DeCoste C, Kang Y (2009) A novel mouse model for
non-invasive single marker tracking of mammary stem cells in vivo reveals stem
cell dynamics throughout pregnancy. PLoS One 4: e8035.
29. Brisken C, Duss S (2007) Stem cells and the stem cell niche in the breast: an
integrated hormonal and developmental perspective. Stem Cell Rev 3: 147–156.
30. Richards J, Pasco D, Yang J, Guzman R, Nandi S (1983) Comparison of the
growth of normal and neoplastic mouse mammary cells on plastic, on collagen
gels and in collagen gels. Exp Cell Res 146: 1–14.
31. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:
402–408.
Mammary SCs Secrete Transgene
PLoS ONE | www.plosone.org 8 October 2010 | Volume 5 | Issue 10 | e13372
